Unobtrusive Technologies for Monitoring of Autonomic Nervous System Function in Elderly Frail Patients
NCT ID: NCT04636970
Last Updated: 2022-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2020-11-19
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Prescription in Cardiac Rehabilitation Mediated by Autonomic Function
NCT07288840
Home-based Exercise Training in Cardiac Patients
NCT03704025
Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome
NCT04768283
Home-based Cardiac Rehabilitation: Compliance and Effectiveness
NCT03605992
Investigation of a Link Between Heart Rate Variability and Frailty in Geriatric Patients
NCT03585985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Patients randomised to control group will get usual recommendations regarding physical activity after a discharge from inpatient cardiac rehabilitation.
No interventions assigned to this group
Intervention group
Patients randomised to intervention group will continue home exercise training that will last 12 weeks and consists of endurance, flexibility, balance and cardiovascular resistance training performed with low to moderate intensity, in 20-60 minutes sessions, five times a week. Study participants will be asked to wear wrist and chest unobtrusive devices during active day time or at least during the training session and two hours before and after. Study participants well receive telephone calls every other week and were asked to answer questions regarding their health and physical activity.
Home training program
Subjects randomized to the IG will participate at home training program that will last 12 weeks and consists of endurance, flexibility, balance and cardiovascular resistance training performed with low to moderate intensity, in 20-60 minutes sessions, five times a week. Study participants will be asked to wear wrist and chest unobtrusive devices during active day time or at least during the training session and two hours before and after.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home training program
Subjects randomized to the IG will participate at home training program that will last 12 weeks and consists of endurance, flexibility, balance and cardiovascular resistance training performed with low to moderate intensity, in 20-60 minutes sessions, five times a week. Study participants will be asked to wear wrist and chest unobtrusive devices during active day time or at least during the training session and two hours before and after.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 65 years and older.
* 6-minute walk distance (6-MWD) ≥150 meters.
* Patient's agreement to participate in the study.
* Edomonton Frailty Scale score 5 points and more
Exclusion Criteria
* Diseases in the musculoskeletal system or other organs complicating physical activity and exercise training;
* Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that would exclude individuals from participating in CR according to study protocol), including chronic heart failure New York Heart Association Class IV, hemoglobin less than 9 g/dL, wound healing disturbance, cognitive or linguistic deficits.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaunas University of Technology
OTHER
Lithuanian University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eglė Tamulevičiūtė-Prascienė
Head of a Rehabilitation department, Lithuanian University of Health Sciences hospital Kaunas Clinics, Kulautuva rehabilitation hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raimondas Kubilius, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Lithuanian University of Health Sciences, Department of Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva
Kaunas, Kulautuva, Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LUHS002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.